No more chemotherapy for certain cancer! - healthprevention.ch
 
Geneva:
+4122 840 33 34
 
Moscow:
+7(903)720 80 57

No more chemotherapy for certain cancer!

Date: 04/07/2018
Last edited: 04/07/2018

This is a breakthrough: many patients with breast or lung cancer can avoid chemotherapy and its serious side effects, according to studies  that should change the way cancers are treated.

The first good news is for women who have had breast cancer. Up to 70% of them can avoid chemotherapy, depending on the results of an existing genetic test, and be treated with hormonal drugs usually prescribed after an operation to remove the tumor.

Tumor analyzed genetically

As for lung cancer, studies also presented at the big annual cancer conference in Chicago (ASCO) show a new era where patients will see their tumors analyzed genetically. If certain mutations are detected, a tumor-specific drug may be prescribed.

Otherwise, in most cases, the patient will be able to receive a new type of treatment, such as immunotherapy. The majority of patients would therefore avoid nausea, hair loss and other side effects caused by highly toxic chemotherapy.

Thanks to a succession of clinical trials, the entire lung cancer treatment model has been turned upside down, an “extraordinary” change, according to a specialist.

Breast cancer

Currently, many women undergo chemotherapy after the surgical removal of the tumor, in addition to hormone therapy drugs, to prevent the eventual return of cancer.

But an international study on 10,000 women concluded that the level justifying the use of chemotherapy could be revised safely. For years, a genetic test performed on the tumor has predicted the probability of recurrence. This test gives a score between 0 and 100. Until now, chemotherapy was recommended above 25. Below 10, it was not. This posed a dilemma for women in the gray zone, between 11 and 25.

The study showed that for these women, after nine years of follow-up, chemotherapy did not bring anything.

Lung cancer

For the most common type of lung cancer, it is immunotherapy that offers huge hope. Pharmaceutical companies are competing fiercely in this field.

At the conference, a study on the Keytruda, or pembrolizumab made big noise. The American company Merck, known as MSD abroad, has bet everything on it. It is taken intravenously, every three weeks, and has become the best-seller of the laboratory, especially against melanoma and lung cancer.

Immunotherapy drugs help the patient’s immune system do what it is supposed to do: detect and attack the tumor. The method does not work against all types of cancers and can cause serious side effects, sometimes to the point where patients stop treatment.

For the latest clinical trial, funded by MSD, the researchers compared the efficacy of taking Keytruda alone to chemotherapy (the effect of the combination of the two protocols was studied separately, and shows good results in some cases) . Patients first treated with pembrolizumab lived four to eight months longer than those who received only chemotherapy. Above all, they were less likely to suffer serious side effects (18% versus 41%).

 

Comments
Articles
Patient registration form
Topics
Examination Incorpore
nutrition
oncology
prevention
dermatology
cancer
age management
Anti-aging
detoxification
skin
diagnosis
heavy metal
immunology
allergy
cardiology
Genetics
stem cells
liver detox
weight management
oncology treatment
DNA
Fertility
pain
chelation
cosmetology
infertility
liver
Sleep
weight loss
gynecology
gastroenterology
covid19
Examination partner centres
arsenic
Hepatitis C
candida
neurology
urology
radiology
obstetrics
immune system
pregnancy
anti-aging
rehabilitation
check-up
headache
immunotherapy
skincare
heart MRI
breast cancer
Blood pressure
joints
Дерматология
mesotherapy
Apnea
tinnitus
probiotics
NAD+
ulcer
abdominal pain
menopause
research
Allergology treatment
pancreas
gastritis
Allergology
migraine
hyaluronic acid
beau-rivage
sugar
andropause
light therapy
flu vaccine
nutrigenomics
excimer laser
psoriasis
telomere
regeneration
PRP
obstertics
rhesus factor
preventiion
sexuality
gastroscopy
brain surgery awake
mastectomy
digestion
mammography
cellmen
cellcosmet
herniated disc
flu
magnesium
R-loops
Omega-3
shoulder
hand
intestinal flora
depression
iron
second opinion
food intolerances
reflexology
food
vitamin b12
mercury
water
erectile dysfunction
back pain
hip
knee
beauty
exercise
sports
cholesterol
stress
vitamin K
narcosis
diabetes
cellulite
acnea
migraines
chronic headaches
diet
oncoloy
reconstruction
blood test
endometriosis
acne
LED therapy
biopsy
liquid biopsy
oral checkup
propofole
dermatitis
hormones
general surgery
nephrology
kidney
ophthalmology
plastic surgery
lungs
pneumology
proctology
pomegranate
rheumatology
orthopedics
colonoscopy
endocrinology
Treatment programs